DCGI may approve Moderna’s Kovid-19 vaccine

Moderna has sought regulatory approval for its COVID-19 vaccine in India. According to official sources, India’s drug regulator may soon grant Restricted Emergency Use Authorization for Moderna’s Kovid-19 vaccine.

Sources told India Today on Tuesday that the Drug Controller General of India (DCGI) may approve Moderna’s Covid-19 vaccine for emergency use for people aged 18 years and above.

Mumbai-based pharmaceutical company Cipla has filed an application with DCGI seeking permission to import Moderna’s Kovid-19 vaccine into India.

Leave a Reply